Benitec Biopharma Limited (NASDAQ: BNTC), announced acceptance of five presentations at the 19th Annual Meeting of American Society of Gene and Cell Therapy (ASGCT) being held in Washington D.C. on May 4-7, 2016.
Benitec Biopharma Limited (NASDAQ:BNTC) traded 50726 shares and its share price moved up 1.79% to close at $1.71. Benitec Biopharma Limited (NASDAQ:BNTC) quarterly performance is -51.14% while its year to date (YTD) performance is -57.46%.
BLT Price at posting:
11.0¢ Sentiment: Hold Disclosure: Held
